Israel’s Immunai could be the secret weapon to faster drug approvals

An American-Israeli immunomics company has announced another success in supporting a major pharmaceutical company in moving its drugs from the lab to clinical approval, The Jerusalem Post has learned. “With our partners, we have succeeded in meeting agreed-upon deliverables,” said Noam Solomon, CEO of Immunai. “In the past two years, we have had a handful […]

Continue Reading

Israeli Innovation Authority unveils ambitious hi-tech stimulus

In a move aimed at enhancing Israel’s global position as a hi-tech hub, the Israeli Innovation Authority (IIA), in collaboration with the Finance Ministry, has approved a comprehensive stimulus package designed to uplift the nation’s hi-tech ecosystem. The plans have been carefully crafted in response to both global and local factors that characterized 2023, such […]

Continue Reading